189 related articles for article (PubMed ID: 33142373)
1. [Peripheral T and B lymphocytes in patients with occupational medicamentosa-like dermatitis due to trichloroethylene].
Deng LD; Deng LH; Lin DF; Tang HY; Wang DP; Luo B; Tong XD; Zhang W
Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi; 2020 Oct; 38(10):731-735. PubMed ID: 33142373
[No Abstract] [Full Text] [Related]
2. [Dynamic change study of dermatitis medicamentosa-like of trichloroethylene patients with liver damage].
Liu W; Zhang YF; Zhang ZM; Li PM; Jiang XD; Zhou GF; Liu JJ
Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi; 2011 Oct; 29(10):790-3. PubMed ID: 22468317
[TBL] [Abstract][Full Text] [Related]
3. CD4+CD25+CD127-Foxp3+ and CD8+CD28- Tregs in Renal Transplant Recipients: Phenotypic Patterns, Association With Immunosuppressive Drugs, and Interaction With Effector CD8+ T Cells and CD19+IL-10+ Bregs.
Aly MG; Ibrahim EH; Karakizlis H; Weimer R; Opelz G; Morath C; Zeier M; Ekpoom N; Daniel V
Front Immunol; 2021; 12():716559. PubMed ID: 34335631
[TBL] [Abstract][Full Text] [Related]
4. IL-10-producing regulatory B-cells suppressed effector T-cells but enhanced regulatory T-cells in chronic HBV infection.
Liu Y; Cheng LS; Wu SD; Wang SQ; Li L; She WM; Li J; Wang JY; Jiang W
Clin Sci (Lond); 2016 Jun; 130(11):907-19. PubMed ID: 26980345
[TBL] [Abstract][Full Text] [Related]
5. Interleukin-35 promotes Breg expansion and interleukin-10 production in CD19
Zhang Y; Wei S; Wu Q; Shen X; Dai W; Zhang Z; Chen M; Huang H; Ma L
Clin Rheumatol; 2022 Aug; 41(8):2403-2416. PubMed ID: 35420296
[TBL] [Abstract][Full Text] [Related]
6. Comparison of peripheral blood B cell subset ratios and B cell-related cytokine levels between ocular and generalized myasthenia gravis.
Hu Y; Wang J; Rao J; Xu X; Cheng Y; Yan L; Wu Y; Wu N; Wu X
Int Immunopharmacol; 2020 Mar; 80():106130. PubMed ID: 31978800
[TBL] [Abstract][Full Text] [Related]
7. Immunophenotyping of peripheral immunoregulatory as well as Th17A and Th22 cell subpopulations in kidney transplant recipients under belatacept or cyclosporine treatment.
Furuzawa-Carballeda J; Bostock IC; Lima G; Mancilla-Urrea E; Mondragón G; Reyes-Acevedo R; Chevaile A; Morales-Buenrostro LE; Llorente L; Alberú J
Transpl Immunol; 2014 Mar; 30(2-3):107-13. PubMed ID: 24561014
[TBL] [Abstract][Full Text] [Related]
8. PD-L1 is a critical mediator of regulatory B cells and T cells in invasive breast cancer.
Guan H; Wan Y; Lan J; Wang Q; Wang Z; Li Y; Zheng J; Zhang X; Wang Z; Shen Y; Xie F
Sci Rep; 2016 Oct; 6():35651. PubMed ID: 27762298
[TBL] [Abstract][Full Text] [Related]
9. Differences of Circulating CD25
Zhang J; Fu Q; He Y; Lv H; Qian Y; Zhang Y; Chen H; Xu X; Yang T; Xu K
J Immunol Res; 2022; 2022():2269237. PubMed ID: 35083339
[TBL] [Abstract][Full Text] [Related]
10. Peripheral regulatory cells immunophenotyping in primary Sjögren's syndrome: a cross-sectional study.
Furuzawa-Carballeda J; Hernández-Molina G; Lima G; Rivera-Vicencio Y; Férez-Blando K; Llorente L
Arthritis Res Ther; 2013; 15(3):R68. PubMed ID: 23800367
[TBL] [Abstract][Full Text] [Related]
11. CD19(+)IL-10(+) regulatory B cells affect survival of tongue squamous cell carcinoma patients and induce resting CD4(+) T cells to CD4(+)Foxp3(+) regulatory T cells.
Zhou X; Su YX; Lao XM; Liang YJ; Liao GQ
Oral Oncol; 2016 Feb; 53():27-35. PubMed ID: 26631955
[TBL] [Abstract][Full Text] [Related]
12. Treg cells are negatively correlated with increased memory B cells in pre-eclampsia while maintaining suppressive function on autologous B-cell proliferation.
Zeng B; Kwak-Kim J; Liu Y; Liao AH
Am J Reprod Immunol; 2013 Dec; 70(6):454-63. PubMed ID: 24033608
[TBL] [Abstract][Full Text] [Related]
13. Targeting CD38 is lethal to Breg-like chronic lymphocytic leukemia cells and Tregs, but restores CD8+ T-cell responses.
Manna A; Kellett T; Aulakh S; Lewis-Tuffin LJ; Dutta N; Knutson K; Chini E; Pinilla-Ibarz J; Lamanna N; Manochakian R; Malavasi F; Sher T; Chanan-Khan AA; Ailawadhi S; Paulus A
Blood Adv; 2020 May; 4(10):2143-2157. PubMed ID: 32421811
[TBL] [Abstract][Full Text] [Related]
14. CD19+CD24hiCD38hiBregs involved in downregulate helper T cells and upregulate regulatory T cells in gastric cancer.
Wang WW; Yuan XL; Chen H; Xie GH; Ma YH; Zheng YX; Zhou YL; Shen LS
Oncotarget; 2015 Oct; 6(32):33486-99. PubMed ID: 26378021
[TBL] [Abstract][Full Text] [Related]
15. [Staging of occupational medicamentosa-like dermatitis due to trichloroethylene].
Lin DF; Xie JW; Huang L; Zhang YF; Huang XQ
Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi; 2020 Jun; 38(6):450-455. PubMed ID: 32629578
[No Abstract] [Full Text] [Related]
16. The advantage of Sirolimus in amplifying regulatory B cells and regulatory T cells in liver transplant patients.
Song J; Du G; Chen W; Bao P; Li B; Lu Q; Shi B
Eur J Pharmacol; 2020 Feb; 869():172872. PubMed ID: 31846626
[TBL] [Abstract][Full Text] [Related]
17. Perioperative dynamic alterations in peripheral regulatory T and B cells in patients with hepatocellular carcinoma.
Chen T; Song D; Min Z; Wang X; Gu Y; Wei B; Yao J; Chen K; Jiang Z; Xie H; Zhou L; Zheng S
J Transl Med; 2012 Jan; 10():14. PubMed ID: 22272696
[TBL] [Abstract][Full Text] [Related]
18. [The proportion of CD19
Xie Z; Dai L; He H; Hong D; Wang Y; Xu W; Chen Z; Li B; Xie C
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2024 Feb; 40(2):148-157. PubMed ID: 38284256
[TBL] [Abstract][Full Text] [Related]
19. The role of regulatory B cells (Bregs) in the Tregs-amplifying effect of Sirolimus.
Song J; Xiao L; Du G; Gao Y; Chen W; Yang S; Fan W; Shi B
Int Immunopharmacol; 2016 Sep; 38():90-6. PubMed ID: 27258186
[TBL] [Abstract][Full Text] [Related]
20. Deficit of circulating CD19
Zaimoku Y; Patel BA; Kajigaya S; Feng X; Alemu L; Quinones Raffo D; Groarke EM; Young NS
Br J Haematol; 2020 Aug; 190(4):610-617. PubMed ID: 32311088
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
